NEW YORK, Sept. 28 (GenomeWeb News) - Invitrogen has created a Vector NTI Open Access policy and the online Vector NTI User Community in conjunction with the release of Vector NTI Advance 10, the latest version of its NTI sequence analysis software, the firm said today.
According to the company, the Open Access policy will enable researchers in not-for-profit laboratories to apply for free, annual, and renewable licenses of Vector NTI. The User Community is designed to serve as an online meeting place for researchers to acquire the latest versions of the software, obtain technical resources, and communicate with Invitrogen and other users, Invitrogen said.
Greg Lucier, chairman and CEO of Invitrogen, said the company anticipates "having tens of thousands of users in the academic, government and research institutions take advantage of our Open Access policy."
Invitrogen said that the Wellcome Trust Sanger Institute and The Scripps Research Institute are both Open Access participants.
GenomeWeb News' sister publication BioInform reported on the developments surrounding Vector NTI two weeks ago.